及早发现癌症仍然是对抗癌症的最佳方法。这个疾病是全世界第二大杀手，几乎所有人生活中都有人被癌症影响。但是，市面上大部分的资源都是在治疗癌症上，而现在的治疗方案都不是非常全面或者完美，以及都是在治疗晚期癌症。在这本充满专业以及权威研究的书中，作者们探讨了一个重要的环节：早期发现以及诊断的重要性。他们探讨了不同筛选方案如何针对不同的癌症。他们研究了这背后的科学，以及在社会面上对于广泛的早期检测的挑战。他们希望呼吁读者以及大众关于早期诊断的重要性，这是一个可以救命的动作，尤其是在弱势群体的人群中。

好评：

“Drawing on success stories with cervical, lung, prostate, and colon cancer, [Ratner and Bonislawski] provide clear examples of effective screening programs . . . that have reduced not only overall cancer mortality but also healthcare disparities. A wonderful voice of optimism, balanced caution, and a path forward.” —Jose G. Guillem, MD

关于作者：

Bruce Ratner has led an eclectic life. After focusing much of his undergraduate coursework on math, biology, and physics, he started his career in law and public service. In his late 30s, he moved into real estate, becoming one of the city’s largest developers. In 2016, Ratner’s brother, Michael, died of metastatic cancer. Through this tragedy, Ratner came to realize that early detection was the key to reducing cancer mortality. Following his brother’s death, he founded a non-profit, the Michael D. Ratner Center for Early Detection of Cancer, to research and promote better cancer screening.

Adam Bonislawski is a science writer with more than 10 years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer and early detection. His writing ranges widely over academic research, companies and technologies. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors,  and he has scientific and media contacts at many of the major cancer and academic research centers in the United States and Europe. In addition to his work as a science writer, Adam writes about business and real estate for the Wall Street Journal, New York Post, and Commercial Observer.